NCT00388960 Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00375193 Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy Status COMPLETED Phase PHASE2
NCT00374140 Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00363415 Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE3
NCT00349492 A Study Comparing Etoposide/Cisplatin With Irinotecan/Cisplatin to Treat Extensive Disease Small Lung Cancer Status COMPLETED Phase PHASE3
NCT00319969 Study Comparing Amrubicin Versus Topotecan in Patients With Small Cell Lung Cancer Who Have Responded to Prior Therapy. Status COMPLETED Phase PHASE2
NCT00317200 A Study of Paclitaxel Plus Bevacizumab in Patients With Chemosensitive Relapsed Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00316433 Oxaliplatin/CPT-11 for Extensive Stage Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00298896 Safety and Efficacy Clinical Study of SNS-595 in Patients With Advanced Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00298688 A Study of IRESSA in Relapsed and Refractory Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00294190 Higher Dose Weekly Topotecan In The Treatment Of Patients With Extensive Stage Small-Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00290953 Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide Status COMPLETED Phase PHASE2/PHASE3
NCT00216216 Pemetrexed in Patients With Chemosensitive and Chemoresistant Relapsed Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00213798 Detection of Plasma DNA in Non Small Cell and Small Cell Lung Cancer Patients Status COMPLETED Phase NA
NCT00178698 Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors Status UNKNOWN Phase PHASE2
NCT00168896 A Study for Small Cell Lung Cancer (SCLC) in Extensive Disease Stage Status UNKNOWN Phase PHASE2/PHASE3
NCT00156286 Gleevec Maintenance Therapy After Induction Irinotecan and Cisplatin in Patients With C-Kit Positive Extensive SCLC Status COMPLETED Phase PHASE2
NCT00132704 An Analysis of the Response of Human Tumor Microvascular Endothelium to Ionizing Radiation Status COMPLETED Phase N/A
NCT00119613 A Study of Subjects With Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated With Platinum Plus Etoposide Chemotherapy With or Without Darbepoetin Alfa Status COMPLETED Phase PHASE3